Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2012

01-04-2012 | Case report

Xylometazoline abuse

Hypertensive crisis and end-organ damage: case report

Published in: Reactions Weekly | Issue 1/2012

Login to get access

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
…
Literature
1.
Buysschaert I, Van Dorpe J, Dujardin K.Hypertensive crisis and end-organ damage induced by over-the-counter nasal decongestant abuse. European Heart Journal 32: 3114, No. 24, Dec 2011 - Belgium
Metadata
Title
Xylometazoline abuse
Hypertensive crisis and end-organ damage: case report
Publication date
01-04-2012
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2012
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201213960-00148

Other articles of this Issue 1/2012

Reactions Weekly 1/2012 Go to the issue

Case report

Lithium

Case report

Tadalafil/vardenafil

Case report

Methotrexate

Case report

Ceftriaxone/meropenem

Case report

Aspirin overdose

Case report

Adalimumab/etanercept/methotrexate